These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 5388578)

  • 1. The effect of chronic barbitone administration and withdrawal on the sensitivity of the central nervous system to barbiturate.
    Stevenson IH; Turnbull MJ
    Br J Pharmacol; 1969 Oct; 37(2):502P-503P. PubMed ID: 5388578
    [No Abstract]   [Full Text] [Related]  

  • 2. The sensitivity of the brain to barbiturate during chronic administration and withdrawal of barbitone sodium in the rat.
    Stevenson IH; Turnbull MJ
    Br J Pharmacol; 1970 Jun; 39(2):325-33. PubMed ID: 5463901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Barbiturate tolerance and physical dependence: contribution of pharmacological factors.
    Okamoto M
    NIDA Res Monogr; 1984; 54():333-47. PubMed ID: 6442760
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparison of ethanol and barbiturate physical dependence.
    Okamoto M; Hinman DJ; Aaronson LM
    J Pharmacol Exp Ther; 1981 Sep; 218(3):701-8. PubMed ID: 7196450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanisms contributing to barbiturate intolerance in rats.
    Aston R
    Br J Pharmacol; 1973 Nov; 49(3):527-33. PubMed ID: 4777712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of chronic administration and withdrawal of sodium barbitone on protein synthesis of rat brain.
    Leite JR; Arnaiz GR
    Pharmacol Biochem Behav; 1978 Apr; 8(4):323-6. PubMed ID: 566928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Studies on the development of physical dependence on barbitone in the rat and rat atrium.
    Arblaster CI; Cameron DW; Laycock GM; Shulman A
    Farmaco Sci; 1986 Jan; 41(1):3-22. PubMed ID: 3956717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The brain acetylcholine system in barbitone-dependent and withdrawn rats.
    McBride A; Turnbull MJ
    Br J Pharmacol; 1970 May; 39(1):210P-211P. PubMed ID: 5463270
    [No Abstract]   [Full Text] [Related]  

  • 9. [Pharmacologic problems related to abstinence and habit phenomena in rats].
    Maffii G; Banfi S
    Boll Chim Farm; 1968 Feb; 107(2):110-9. PubMed ID: 5753385
    [No Abstract]   [Full Text] [Related]  

  • 10. Characteristics of functional tolerance during barbiturate physical dependency production.
    Okamoto M; Boisse NR; Rosenberg HC; Rosen R
    J Pharmacol Exp Ther; 1978 Dec; 207(3):906-15. PubMed ID: 569696
    [No Abstract]   [Full Text] [Related]  

  • 11. Study of development of tolerance to and barbiturate-like physical dependence on the tranquilizer tempidon.
    Nikolova M; Daleva L; Nikolov R
    Agressologie; 1975; 16 Spec No C():43-7. PubMed ID: 1241886
    [No Abstract]   [Full Text] [Related]  

  • 12. Hexobarbitone response in barbitone-dependent and withdrawn rats.
    Stevenson IH; Turnbull MJ
    Br J Pharmacol; 1968 Sep; 34(1):210P-211P. PubMed ID: 5692083
    [No Abstract]   [Full Text] [Related]  

  • 13. Demonstration of neurochemical tolerance following chronic barbital treatment.
    Lane SJ; Morgan WW
    Neurobehav Toxicol Teratol; 1985; 7(2):195-7. PubMed ID: 2987720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of the barbiturate abstinence syndrome.
    Sullivan JT; Sellers EM
    Med J Aust; 1986 Nov; 145(9):456-8. PubMed ID: 3773832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Some endocrinological aspects of barbiturate dependence.
    Norton PR
    Br J Pharmacol; 1971 Feb; 41(2):317-30. PubMed ID: 5103092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of tolerance to and physical dependence on barbiturates in rhesus monkeys.
    Yanagita T; Takahashi S
    J Pharmacol Exp Ther; 1970 Mar; 172(1):163-9. PubMed ID: 4984668
    [No Abstract]   [Full Text] [Related]  

  • 17. [Experimental pssibilities in the appraisal of drug addiction potentials].
    Cerletti A
    Bull Schweiz Akad Med Wiss; 1971 Jun; 27(1):31-8. PubMed ID: 5168783
    [No Abstract]   [Full Text] [Related]  

  • 18. Physical dependence produced by long duration, low dose chronic barbital treatment.
    Okamoto M; Hinman DJ
    Subst Alcohol Actions Misuse; 1984; 5(2):97-103. PubMed ID: 6540898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Withdrawal treatment for barbiturate dependence.
    Teggin AF; Bewley TH
    Practitioner; 1979 Jul; 223(1333):106-7. PubMed ID: 482237
    [No Abstract]   [Full Text] [Related]  

  • 20. Hepatic drug-metabolising enzyme activity and duration of hexobarbitone anaesthesia in barbitone-dependent and withdrawn rats.
    Stevenson IH; Turnbull MJ
    Biochem Pharmacol; 1968 Nov; 17(11):2297-305. PubMed ID: 5752725
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.